General MedicationsINJECTIONGeneric
KANAMYCIN SULFATE
KANAMYCIN SULFATE
Standard Dose
EQ 75MG BASE/2ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview KANAMYCIN SULFATE is listed in Drugs@FDA under application 063021 (ANDA).
Marketing status: Discontinued Active ingredient KANAMYCIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 75MG BASE/2ML Sponsor LOCH Submission history Latest submission status date: 1992-07-31 00:00:00.
Structured Monograph
Clinical summary
Approval overview KANAMYCIN SULFATE is listed in Drugs@FDA under application 063021 (ANDA). Marketing status: Discontinued Active ingredient KANAMYCIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 75MG BASE/2ML Sponsor LOCH Submission history Latest submission status date: 1992-07-31 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.